Ganga Pharmaceuticals (BOM:539680) EV-to-Revenue : 2.79 (As of May. 04, 2025)

Ganga Pharmaceuticals EV-to-Revenue Chart

Ganga Pharmaceuticals Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
EV-to-Revenue		Get a 7-Day Free Trial					1.41	2.00	2.53	2.88	4.80

Ganga Pharmaceuticals Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
EV-to-Revenue	Get a 7-Day Free Trial															-	2.88	-	4.80	-

Competitive Comparison of Ganga Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Ganga Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ganga Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ganga Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ganga Pharmaceuticals's EV-to-Revenue falls into.

Ganga Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Ganga Pharmaceuticals's EV-to-Revenue for today is calculated as:

Ganga Pharmaceuticals's current Enterprise Value is ₹76.19 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ganga Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ₹27.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ganga Pharmaceuticals  (BOM:539680) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Ganga Pharmaceuticals's PS Ratiofor today is calculated as:

Ganga Pharmaceuticals's share price for today is ₹13.51.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2024 was ₹5.65.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ganga Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ganga Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Ganga Pharmaceuticals Business Description